health sciences authority of singapore

Lion TCR’s T-Cell Therapy Gets Phase I/II Trial Approval

Singapore’s Health Sciences Authority has approved Lion TCR’s Phase I/II clinical study of immunotherapy for liver cancer.

Supplements: Too Much Of A “Good” Thing?

I don't want for us to take pills anymore, not that it's bad. We'll be stronger if we don't need them.

HSA Approves Lung Cancer Drug Giotrif®

Singaporean non-small cell lung cancer patients with EGFR mutations can look forward to new treatment possibilities with Boehringer Ingelheim's Giotrif®.

Adaptive Licensing To Speed Up Drug Approvals In Singapore

Singapore's health regulatory agency is implementing a new drug development regulatory model to accelerate the translation of drugs into the clinic.

How Do We Regulate Cell & Tissue Therapeutic Products?

Singapore is leading the regulatory harmonization for cell- and tissue-based therapeutic products, says an HSA regulatory specialist.